TY - JOUR AU - Larkin, J. AU - Chiarion-Sileni, V. AU - Gonzalez, R. AU - Grob, J. J. AU - Cowey, C. L. AU - Lao, C. D. PY - 2015 DA - 2015// TI - Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504030 DO - 10.1056/NEJMoa1504030 ID - Larkin2015 ER - TY - JOUR AU - Zimmer, L. AU - Apuri, S. AU - Eroglu, Z. AU - Kottschade, L. A. AU - Forschner, A. AU - Gutzmer, R. PY - 2017 DA - 2017// TI - Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma JO - Eur J Cancer VL - 75 UR - https://doi.org/10.1016/j.ejca.2017.01.009 DO - 10.1016/j.ejca.2017.01.009 ID - Zimmer2017 ER - TY - JOUR AU - Kirchberger, M. C. AU - Hauschild, A. AU - Schuler, G. AU - Heinzerling, L. PY - 2016 DA - 2016// TI - Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma JO - Eur J Cancer VL - 65 UR - https://doi.org/10.1016/j.ejca.2016.07.003 DO - 10.1016/j.ejca.2016.07.003 ID - Kirchberger2016 ER - TY - JOUR AU - Cortazar, F. B. AU - Marrone, K. A. AU - Troxell, M. L. AU - Ralto, K. M. AU - Hoenig, M. P. AU - Brahmer, J. R. PY - 2016 DA - 2016// TI - Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors JO - Kidney Int VL - 90 UR - https://doi.org/10.1016/j.kint.2016.04.008 DO - 10.1016/j.kint.2016.04.008 ID - Cortazar2016 ER - TY - JOUR AU - Eigentler, T. K. AU - Hassel, J. C. AU - Berking, C. AU - Aberle, J. AU - Bachmann, O. AU - Grunwald, V. PY - 2016 DA - 2016// TI - Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy JO - Cancer Treat Rev VL - 45 UR - https://doi.org/10.1016/j.ctrv.2016.02.003 DO - 10.1016/j.ctrv.2016.02.003 ID - Eigentler2016 ER - TY - JOUR AU - Hofmann, L. AU - Forschner, A. AU - Loquai, C. AU - Goldinger, S. M. AU - Zimmer, L. AU - Ugurel, S. PY - 2016 DA - 2016// TI - Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy JO - Eur J Cancer VL - 60 UR - https://doi.org/10.1016/j.ejca.2016.02.025 DO - 10.1016/j.ejca.2016.02.025 ID - Hofmann2016 ER - TY - JOUR AU - Belliere, J. AU - Meyer, N. AU - Mazieres, J. AU - Ollier, S. AU - Boulinguez, S. AU - Delas, A. PY - 2016 DA - 2016// TI - Acute interstitial nephritis related to immune checkpoint inhibitors JO - Br J Cancer VL - 115 UR - https://doi.org/10.1038/bjc.2016.358 DO - 10.1038/bjc.2016.358 ID - Belliere2016 ER - TY - JOUR AU - Murakami, N. AU - Borges, T. J. AU - Yamashita, M. AU - Riella, L. V. PY - 2016 DA - 2016// TI - Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma JO - Clin Kidney J VL - 9 UR - https://doi.org/10.1093/ckj/sfw024 DO - 10.1093/ckj/sfw024 ID - Murakami2016 ER - TY - JOUR AU - Gao, B. AU - Lin, N. AU - Wang, S. AU - Wang, Y. PY - 2018 DA - 2018// TI - Minimal change disease associated with anti-PD1 immunotherapy: a case report JO - BMC Nephrol VL - 19 UR - https://doi.org/10.1186/s12882-018-0958-6 DO - 10.1186/s12882-018-0958-6 ID - Gao2018 ER - TY - JOUR AU - Kitchlu, A. AU - Fingrut, W. AU - Avila-Casado, C. AU - Chan, C. T. AU - Crump, M. AU - Hogg, D. PY - 2017 DA - 2017// TI - Nephrotic syndrome with Cancer immunotherapies: a report of 2 cases JO - Am J Kidney Dis VL - 70 UR - https://doi.org/10.1053/j.ajkd.2017.04.026 DO - 10.1053/j.ajkd.2017.04.026 ID - Kitchlu2017 ER - TY - JOUR AU - Audard, V. AU - Larousserie, F. AU - Grimbert, P. AU - Abtahi, M. AU - Sotto, J. J. AU - Delmer, A. PY - 2006 DA - 2006// TI - Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature JO - Kidney Int VL - 69 UR - https://doi.org/10.1038/sj.ki.5000341 DO - 10.1038/sj.ki.5000341 ID - Audard2006 ER - TY - JOUR AU - Kramer, P. AU - Sizoo, W. AU - Twiss, E. E. PY - 1981 DA - 1981// TI - Nephrotic syndrome in Hodgkin's disease. Report of five cases and review of the literature JO - Neth J Med VL - 24 ID - Kramer1981 ER - TY - JOUR AU - Plager, J. AU - Stutzman, L. PY - 1971 DA - 1971// TI - Acute nephrotic syndrome as a manifestation of active Hodgkin's disease. Report of four cases and review of the literature JO - Am J Med VL - 50 UR - https://doi.org/10.1016/0002-9343(71)90205-1 DO - 10.1016/0002-9343(71)90205-1 ID - Plager1971 ER - TY - JOUR AU - Ugurel, S. AU - Kiecker, F. AU - Frohling, S. AU - Wetter, A. AU - Bankfalvi, A. AU - Sucker, A. PY - 2017 DA - 2017// TI - Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma JO - Eur J Cancer VL - 83 UR - https://doi.org/10.1016/j.ejca.2017.06.020 DO - 10.1016/j.ejca.2017.06.020 ID - Ugurel2017 ER - TY - JOUR AU - Herz, S. AU - Hofer, T. AU - Papapanagiotou, M. AU - Leyh, J. C. AU - Meyenburg, S. AU - Schadendorf, D. PY - 2016 DA - 2016// TI - Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient JO - Eur J Cancer VL - 67 UR - https://doi.org/10.1016/j.ejca.2016.07.026 DO - 10.1016/j.ejca.2016.07.026 ID - Herz2016 ER -